Popovits Kimberly J

CIK 00013334828 companiesREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001333482

Recent Transactions

50 trades

Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-07-30$15.47/sh+18,760→ 77,054 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-07-30−45,748→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-07-30$29.90/sh−64,508→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-07-30$10.36/sh+45,748→ 58,294 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-07-30−18,760→ 0 total
Award
EXACT SCIENCES CORP$EXAS
Common Stock
2025-06-12+9,994→ 16,381 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-05−3,173→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-05+3,173→ 12,546 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-03+16,798→ 16,798 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2025-06-03+15,357→ 28,616 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-03+2,799→ 2,799 total
Award
EXACT SCIENCES CORP$EXAS
Common Stock
2025-01-02+6,387→ 6,387 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2024-06-11+8,649→ 13,259 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2024-06-06+4,373→ 9,373 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-06−4,373→ 0 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-05+3,173→ 3,173 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2024-06-05+19,040→ 19,040 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2023-06-29+5,000→ 5,000 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-29−5,000→ 0 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2023-06-14+1,865→ 4,610 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2023-06-14+4,661→ 4,661 total
Award
Talis Biomedical Corp$TLIS
Stock option (right to buy)
2023-06-09+95,000→ 95,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-06+4,373→ 4,373 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2023-06-06+26,236→ 26,236 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2022-06-29+5,000→ 5,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2022-06-29+30,000→ 30,000 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2022-06-15+2,120→ 2,745 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2022-06-15+5,300→ 5,300 total
Award
Talis Biomedical Corp$TLIS
Stock Option (right to buy)
2022-06-10+95,000→ 95,000 total
Award
Talis Biomedical Corp$TLIS
Stock Option (right to buy)
2021-08-30+550,000→ 550,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2021-06-29+33,237→ 33,237 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2021-06-11+625→ 625 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2021-06-11+1,563→ 1,563 total
Conversion
Talis Biomedical Corp$TLIS
Series E-1 Preferred Stock
2021-02-17−131,642→ 0 total
Conversion
Talis Biomedical Corp$TLIS
Series E-1 Preferred Stock
2021-02-17−300,000→ 0 total
Conversion
Talis Biomedical Corp$TLIS
Series C-1 Preferred Stock
2021-02-17−31,519→ 0 total
Conversion
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17+89,968→ 182,025 total
Conversion
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17+92,057→ 92,057 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17$16.00/sh+5,300→ 215,090 total
Conversion
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17+209,790→ 209,790 total
Conversion
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17+22,041→ 25,776 total
Conversion
Talis Biomedical Corp$TLIS
Series F-1 Preferred Stock
2021-02-17−128,655→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−11,000→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−6,600→ 0 total
Disposition from Tender
MyoKardia, Inc.
Common Stock
2020-11-17−4,100→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−22,000→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−3,000→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−11,000→ 0 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2020-06-30+18,760→ 18,760 total
Award
MyoKardia, Inc.
Stock Option (Right to Buy)
2020-06-18+3,000→ 3,000 total

Companies

Recent Filings

Address

301 PENOBSCOT DRIVE

REDWOOD CITY, CA, 94403

View on SEC.gov